Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TWLO vs GSK✓SelectedUSD · GSKTWLO vs GSK performance historyLatest closeAs of-5.58%11/16
Stock and ETF performance explorer

TWLO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+438.2%
GSK return
+107.3%
Excess return
+331.0%
Maximum drawdown
-90.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.6%-0.1%-5.5%-5.6%
7D-3.5%-1.3%-2.2%-3.2%
30D-18.4%+2.7%-21.1%-19.0%
3M-16.3%+2.7%-19.0%-17.0%
6M+0.6%+3.3%-2.8%-0.7%
YTD+40.2%+6.5%+33.7%+36.1%
1Y+59.1%+10.7%+48.4%+52.9%
3Y+224.0%+64.4%+159.6%+170.3%
5Y-35.8%+46.7%-82.5%-45.2%
10Y+438.2%+109.4%+328.9%+328.1%
All+438.2%+107.3%+331.0%+328.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling